Schedule 13D ownership disclosure
MABVAX THERAPEUTICS HOLDINGS, INC.
Security class unavailable · CUSIP: 55414P504
Event date: 2018-07-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-18-010411
- Form type
- SC 13D
- Filer
- MABVAX THERAPEUTICS HOLDINGS, INC.
- CIK
- CIK 1109196
- Filed
- Jul 25, 2018
- Reporting period
- Jul 24, 2018
- Description
- Schedule 13D beneficial ownership